Skip Navigation



Glycobiology Advance Access published online on November 3, 2004

Glycobiology, doi:10.1093/glycob/cwi011
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
15/3/259    most recent
cwi011v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chen, W.
Right arrow Articles by Stanley, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.
Right arrow Articles by Stanley, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received August 13, 2004
Revised October 24, 2004
Accepted October 29, 2004

ORIGINAL ARTICLES

Suppressors of {alpha}(1,3)fucosylation identified by expression cloning in the LEC11B gain-of-function CHO mutant

Wei Chen 1, Jian Tang 1, and Pamela Stanley 1*

1 Dept. Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave., New York, NY 10461

* To whom correspondence should be addressed.
Pamela Stanley, E-mail: stanley{at}aecom.yu.edu


   Abstract

Factors that regulate {alpha}(1,3)fucosyltransferase activity are important to identify because FUT genes are upregulated during inflammation, cancer progression and tumor metastasis. FUT gene activation increases the expression of cell surface oncofetal antigens such as LeX, sialyl-LeX and VIM-2. The LEC11B gain-of-function glycosylation mutant displays these antigens and binds E-selectin because it expresses the Fut6B gene that is shown here to lie immediately downstream of the Fut6A gene. A retroviral strategy for expression cloning factors that suppress {alpha}(1,3)fucosylation in LEC11B cells was developed and several cDNAs that reverted the LEC11B glycosylation phenotype were isolated. cDNAs that arose most frequently and independently encoded SLC35C2 a putative GDP-Fucose transporter (also termed CGI-15 or Ovcov1), Cd63 a tetraspanin membrane protein, and Hdac5 a histone deacetylase. When transfected into LEC11B cells the SLC35C2 cDNA reduced LeX expression with no concomitant suppression of Fut6B gene transcripts. Transfection of the Cd63 cDNA induced low levels of ricin resistance and also did not suppress Fut6B gene transcripts in LEC11B. However, the Hdac5 cDNA induced ricin-resistance, reduced fucosylated antigen expression and essentially eliminated Fut6B gene transcripts. The Hdac5 cDNA isolated by expression cloning encoded the C-terminal region of hamster Hdac5. Overexpression of this partial Hdac5 cDNA or a full length Hdac5 cDNA, suppressed Fut6B gene transcripts specifically. Thus the expression cloning strategy identified Hdac5 as a trans-acting repressor of the CHO Fut6B gene and Cd63 and SLC35C2 as novel factors that suppress {alpha}(1,3)fucosylation by mechanisms unrelated to effects on Fut gene expression.

Keywords: {alpha}(1,3)fucosyltransferase; dominant CHO mutant; expression cloning; LeX suppression.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eukaryot CellHome page
O. W. Liu, M. J. S. Kelly, E. D. Chow, and H. D. Madhani
Parallel {beta}-Helix Proteins Required for Accurate Capsule Polysaccharide Synthesis and Virulence in the Yeast Cryptococcus neoformans
Eukaryot. Cell, April 1, 2007; 6(4): 630 - 640.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Helmus, J. Denecke, S. Yakubenia, P. Robinson, K. Luhn, D. L. Watson, P. J. McGrogan, D. Vestweber, T. Marquardt, and M. K. Wild
Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter
Blood, May 15, 2006; 107(10): 3959 - 3966.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.